BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12910407)

  • 1. Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy.
    Grötz KA; Genitsariotis S; Vehling D; Al-Nawas B
    Support Care Cancer; 2003 Nov; 11(11):717-21. PubMed ID: 12910407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors.
    Rubira CM; Devides NJ; Ubeda LT; Bortolucci AG; Lauris JR; Rubira-Bullen IR; Damante JH
    Braz Oral Res; 2007; 21(3):272-7. PubMed ID: 17710295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
    Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
    Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of radiation injuries to the salivary glands after treatment of head and neck cancers].
    Urban A; Miszczyk L; Maciejewski B
    Otolaryngol Pol; 2005; 59(1):21-5. PubMed ID: 15915914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
    Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin/Troxerutine in patients with head and neck cancer].
    Grötz KA; Henneicke-von Zepelin HH; Kohnen R; al-Nawas B; Bockisch A; Kutzner J; Wüstenberg P; Naser-Hijazi B; Belz GG; Wagner W
    Strahlenther Onkol; 1999 Aug; 175(8):397-403; discussion 404. PubMed ID: 10481772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supragingival and subgingival microbiota from patients with poor oral hygiene submitted to radiotherapy for head and neck cancer treatment.
    Gaetti-Jardim E; Jardim ECG; Schweitzer CM; da Silva JCL; Oliveira MM; Masocatto DC; Dos Santos CM
    Arch Oral Biol; 2018 Jun; 90():45-52. PubMed ID: 29533791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the "Registry for the evaluation of side effects after radiotherapy in childhood and adolescence".
    Bölling T; Weege J; Eich HT; Timmermann B; Meyer FM; Rübe C; Kortmann RD; Fischedick K; Rödel C; Koch R; Willich N
    Head Neck; 2015 Aug; 37(8):1137-41. PubMed ID: 24764129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
    Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
    J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.
    Oba MK; Innocentini LMAR; Viani G; Ricz HMA; de Carvalho Reis T; Ferrari TC; de Macedo LD
    Support Care Cancer; 2021 Jan; 29(1):127-134. PubMed ID: 32318870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of long-term salivary gland damage induced by radiotherapy.
    Makkonen TA; Nordman E
    Acta Oncol; 1987; 26(4):307-12. PubMed ID: 3689584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
    Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
    Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
    Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
    Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced salivary dysfunction: clinical course and significance.
    Valdez IH
    Spec Care Dentist; 1991; 11(6):252-5. PubMed ID: 1813995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.
    Ashcraft KA; Boss MK; Tovmasyan A; Roy Choudhury K; Fontanella AN; Young KH; Palmer GM; Birer SR; Landon CD; Park W; Das SK; Weitner T; Sheng H; Warner DS; Brizel DM; Spasojevic I; Batinic-Haberle I; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):892-900. PubMed ID: 26530759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.